As of the latest Form 4 filed Jul 6, 2026.
What Jazz Pharmaceuticals PLC insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 27 most recent filings for JAZZ.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-06 | 2026-07-01 | COZADD BRUCE C Director | SSale | −6.00K | $240.47 | $1.44M | Yes (planned) | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Johnson Philip L EVP & Chief Financial Officer | FTax | −3.34K | $237.72 | $795K | No | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Pearce Samantha EVP, Chief Commercial Officer | FTax | −2.53K | $237.72 | $601K | No | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Patil Neena M EVP & Chief Legal Officer | FTax | −2.68K | $237.72 | $637K | No | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | Iannone Robert EVP, Global Head of R&D & CMO | FTax | −3.76K | $237.72 | $895K | No | Form 4 ↗ |
| 2026-07-02 | 2026-06-30 | GALA RENEE D President & CEO | FTax | −4.83K | $237.72 | $1.15M | No | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Smith Mark Douglas Director | SSale | −1.16K | $230.55 | $267K | Yes (planned) | Form 4 ↗ |
| 2026-06-12 | 2026-06-10 | Patil Neena M EVP & Chief Legal Officer | SSale | −1.20K | $231.83 | $278K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-03 | GALA RENEE D President & CEO | GGift | −600.00 | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-03 | 2026-06-01 | COZADD BRUCE C Director | SSale | −6.00K | $235.12 | $1.41M | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Pearce Samantha EVP, Chief Commercial Officer | SSale | −6.91K | $235.41 | $1.63M | No | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Pearce Samantha, EVP, Chief Commercial Officer | MExercise | +6.91K | $109.45 | $756K | No | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Patil Neena M EVP & Chief Legal Officer | SSale | −1.19K | $236.97 | $282K | Yes (planned) | Form 4 ↗ |
| 2026-06-01 | 2026-05-28 | Mulligan Seamus Director | MExercise | +3.42K | $138.08 | $472K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | McSharry Heather Ann Director | SSale | −2.00K | $241.00 | $482K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Winningham Rick E Director | SSale | −2.74K | $241.57 | $662K | No | Form 4 ↗ |
| 2026-05-27 | 2026-05-22 | Winningham Rick E, Director | MExercise | +3.42K | $138.08 | $472K | No | Form 4 ↗ |
| 2026-05-05 | 2026-05-01 | COZADD BRUCE C Director | SSale | −6.00K | $203.33 | $1.22M | Yes (planned) | Form 4 ↗ |
| 2026-03-09 | 2026-03-09 | Carr Patricia SVP, Chief Accounting Officer | SSale | −1.29K | $182.94 | $235K | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Johnson Philip L EVP & Chief Financial Officer | FTax | −2.62K | $188.69 | $493K | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Henderson Mary Elizabeth SVP, Technical Operations | FTax | −1.39K | $186.75 | $260K | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Pearce Samantha EVP, Chief Commercial Officer | FTax | −2.50K | $188.69 | $472K | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Carr Patricia SVP, Chief Accounting Officer | FTax | −1.44K | $186.77 | $268K | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Patil Neena M EVP & Chief Legal Officer | FTax | −5.00K | $188.69 | $943K | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | Iannone Robert EVP, Global Head of R&D & CMO | FTax | −6.21K | $188.69 | $1.17M | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | GALA RENEE D President & CEO | FTax | −7.07K | $188.69 | $1.33M | No | Form 4 ↗ |
| 2026-03-09 | 2026-03-05 | COZADD BRUCE C Director | FTax | −15.1K | $188.69 | $2.85M | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also JAZZ’s full analysis or the market-wide insider trading feed. The tabs above jump to JAZZ’s other SEC data.
Source: SEC Form 4 filings for JAZZ, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.